KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹18 Cr | ₹20 Cr | ₹41 Cr | ₹21 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹21 Cr |
How is Contingent Liabilities of KOPRAN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | -5.24 | |
| Mar2024 | ₹18 Cr | -9.05 | |
| Mar2023 | ₹20 Cr | -51.22 | |
| Mar2022 | ₹41 Cr | 93.30 | |
| Mar2021 | ₹21 Cr | - | |
Compare Contingent Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹613.9 Cr | -1.2% | 0.8% | -28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -1.2% |
0.8% |
-28% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses